ArticleIn vivo (Athens, Greece)
Development of a Glymphatic Pathway-based Rat Model for Cancer Metastasis from Brain to Lung.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimBrain-to-lung metastasis is clinically rare but represents an underexplored route of cancer dissemination. Understanding this process may reveal novel mechanisms involving cerebrospinal fluid (CSF) and glymphatic clearance pathways. Existing preclinical models fail to replicate this directional spread or allow controlled investigation of central nervous system (CNS)-driven metastasis. This study aimed to develop a reproducible rat model to examine whether tumor cells introduced into the CNS can disseminate to peripheral organs, specifically the lungs. MATERIALS AND
methodsWe established a brain-to-lung metastatic model in immunocompromised nude rats using intrathecal injection of A549-LUC human lung adenocarcinoma cells. This approach enabled precise tumor placement within the subarachnoid space for controlled modeling of metastatic progression.
resultsIVIS imaging revealed early tumor localization in the CNS, followed by progressive and asymmetric spread to the lungs, with higher radiance in the right lung. Intracranial tumor detection was limited by poor signal penetration through the skull. Post-mortem hematoxylin and eosin staining confirmed tumor lesions in brain and lung tissues. Physiological monitoring showed initial weight gain followed by decline, and survival analysis indicated a median survival of 36 days, with complete mortality by day 40.
conclusionThis intrathecal model overcomes limitations of systemic injection techniques by enabling stepwise investigation of brain-to-lung metastasis. While immune interactions are restricted, this reproducible platform supports therapeutic testing - including ultrasound-enhanced glymphatic drug delivery - and provides a foundation for studying rare but clinically significant metastatic routes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.